SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): July 7, 2003
Orchid BioSciences, Inc.
Delaware (State or other jurisdiction of incorporation) | | 000-30267 (Commission File Number) | | 22-3392819 (IRS Employer Identification No.) |
4390 US Route One, Princeton, NJ (Address of principal executive offices) | | | | 08540 (Zip Code) |
Registrant’s telephone number, including area code: (609) 750-2200
On July 7, 2003, the Registrant publicly issued a press release to announce that the Registrant has appointed Michael E. Spicer as Chief Financial Officer. A copy of the press release is attached to this current report on Form 8-K as Exhibit 99.1 and incorporated herein by reference.
| Item 7. | | Financial Statements and Exhibits. |
99.1 | | Press Release of the Registrant dated July 7, 2003. |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| | | | | ORCHID BIOSCIENCES, INC. (Registrant) |
| | | |
Date: July 14, 2003 | | | | By: | | /s/ PAUL J. KELLY
|
| | | | | | | Title: | | Paul J. Kelly Chief Executive Officer |
